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SUMMARY
Coral snakes (Micrurus spp.) are the main representatives of the Elapidae in South America. However, bites by these snakes
are uncommon. We retrospectively reviewed the data from 11 individuals bitten by coral snakes over a 20-year period; four were
confirmed (snake brought for identification) and seven were highly suspected (neuromuscular manifestations) cases of elapid
envenoming. The cases were classified as dry-bite (n = 1, caused by M. lemniscatus; did not receive antivenom), mild (n = 2, local
manifestations with no acute myasthenic syndrome; M. frontalis and Micrurus spp.), moderate (n = 5, mild myasthenia) or severe
(n = 3, important myasthenia; one of them caused by M. frontalis). The main clinical features upon admission were paresthesia
(local, n = 9; generalized, n = 2), local pain (n = 8), palpebral ptosis (n = 8), weakness (n = 4) and inability to stand up (n = 3). No
patient developed respiratory failure. Antivenom was used in ten cases, with mild early reactions occurring in three. An
anticholinesterase drug was administered in the three severe cases, with a good response in two. No deaths were observed. Despite
the high toxicity of coral snake venoms, the prognosis following envenoming is good. In serious bites by M. frontalis or M.
lemniscatus, the venom of which acts postsynaptically, anticholinesterases may be useful as an ancillary measure if antivenom is
unavailable, if there is a delay in obtaining a sufficient amount, or in those patients given the highest recommended doses of
antivenom without improvement of the paralysis or with delayed recovery.
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INTRODUCTION
In the Americas, the main representatives of the Elapidae family
are the snakes of the genus Micrurus (coral snakes), of which 19 species
with a wide distribution occur in Brazil20. Bites by these species are
uncommon and are the fourth cause of bites by venomous snakes in
Brazil6. Coral snakes accounted for 0.65% (n = 486) of the 75,312
bites by venomous snakes in Brazil for which the genus was officially
notified from 2001 to 2004, with no record of any deaths (Secretaria
de Vigilância em Saúde, Ministério da Saúde do Brasil, 2005,
unpublished data). By comparison, a frequency of less than 2% (out of
all snakebites) has been estimated for bites by Micrurus species in
Central America5, and in the United States, bites by coral snakes (mainly
Micrurus fulvius) account from 3.6% of those involving indigenous
venomous snakes, based on records for the last 20 years (1983-2003)
(911 coral snake bites in a total of 25,551 bites by venomous snakes)1.
Experimental studies have shown that Micrurus venoms are neurotoxic
(their most important clinical effect)2,7,12,17,31,32, myotoxic14, hemorrhagic4,12
and edematogenic7, and some also are hemolytic7. The neurotoxins present
in Micrurus venoms act either presynaptically (molecular mass of 12-60
kDa, with phospholipase A2 activity, as in the case of M. corallinus)
blocking the release of acetylcholine at the neuromuscular junction, or
postsynaptically (molecular mass of 6-14 kDa, with no enzymatic activity,
such as present in the venoms of M. frontalis, M. lemniscatus, M.
nigrocinctus and other Micrurus species), by direct competition with
acetylcholine for nicotinic cholinergic receptors in the postsynaptic
membrane, in a manner similar to curare2,7,12,17,31,32.
Whereas there have been detailed clinical reports and summaries
of envenomations by coral snakes (Micrurus fulvius) in North
America18,19,27, most studies of bites caused by Central and South
American species have been published as case reports8,23,26,28,30,32,
although an abstract of a relatively large series of bites (n = 32) by M.
corallinus and M. frontalis in southern Brazil has been published22. In
this paper, we present a retrospective analysis of a series of patients
bitten by coral snakes over a 20-year period, and examined at the
University teaching hospital and the Poison Control Center, School of
Medicine, State University of Campinas (UNICAMP), in Campinas,
Southeastern Brazil.
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PATIENTS AND METHODS
The medical records of 22 patients reportedly bitten by coral snakes
from May 1984 to December 2004 who were admitted to UNICAMP
were individually reviewed by two of the authors (FB and EMDC),
using an abstraction proforma in order to ensure consistency in the
data selection. The variables recorded included time, day and month
of the bite, identification of the offending snake, patient’s age, sex and
origin, bite site, time between the bite and admission to the hospital at
UNICAMP, clinical manifestations, treatment given, including
antivenom and therapeutic tests with anticholinesterase drugs, number
of ampoules of antivenom, frequency and type of early reactions to
antivenom, and general evolution of the case.
A total of 11 patients bitten by coral snakes fulfilled the inclusion
criterion, namely, confirmed identification of the snake or a strong
suspicion of being elapid bites based on the anamnesis (patient reported
being bitten by a coral snake, but did not bring the snake), with clinical
systemic manifestations indicative of acute myasthenic syndrome. All
of the bites were arbitrarily classified as asymptomatic or dry-bites
(with or without discrete local manifestations and which did not receive
antivenom), mild (only local manifestations), moderate (evident signs
of myasthenia, but no overt paralysis) and severe (signs of intense
myasthenia with superficial respiration and inability to walk or remain
in an erect position).
The antivenom used (10 mL/ampoule) was an enriched solution of
F(ab’)2 immunoglobulins obtained from horses immunized with a
mixture of venom from two species, M. frontalis and M. corallinus.
According to the manufacturer (Instituto Butantan, São Paulo, SP,
Brazil), each 10 mL of antivenom neutralizes 15 mg of reference venom
of M. frontalis in mice.
The anticholinesterase drugs used were neostigmine methylsulfate
(Prostigmine®, 1 mL = 0.5 mg) and edrophonium hydrochloride
(Tensilon®, 1 mL = 10 mg). The administration of anticholinesterase
drugs was preceded by treatment with atropine sulfate (1 mL =
0.25 mg).
RESULTS
Table 1 shows the main demographic characteristics of the patients.
Most of the patients were attended within three h of being bitten, with
the most frequently bitten region being the distal segments of the
fingers. A tourniquet was used in only one case.
Table 2 summarizes the principal clinical findings. The offending
snake was identified in four cases (M. frontalis, n = 2, one mild case
and one severe case; M. lemniscatus, n = 1, a dry-bite; Micrurus sp., n
= 1, a mild case). The main local manifestations were pain and
paresthesia. All moderate and severe cases showed neurological
manifestations indicative of myasthenia, with palpebral ptosis being
the most frequent. Fang marks were seen in three cases.
Among the patients classified as moderate, four showed neurotoxic
manifestations within one hour after the bite and one after five hours.
All of them showed progressive improvement after antivenom
administration, with four being discharged 24 h post-admission, when
they had no neuromuscular manifestations.
The three severe cases developed intense muscular weakness,
starting between 2-3 h after the bite. An anticholinesterase (neostigmine,
n = 2; edrophonium, n = 1; preceded by the i.v. administration of
atropine) was used in all three patients, with the two patients who
received neostigmine responding favorably. None of the patients
required artificial ventilation. The first patient (20 years old), who was
admitted to hospital two h after the bite, showed complete recovery
from paralysis 10 min after two i.v. doses (1 mg each) of neostigmine,
with no need for additional doses; this was followed by the
administration of 10 ampoules of antivenom, and discharged after two
days (VITAL BRAZIL & VIEIRA, 1996). The second patient (38 years
old) was admitted to UNICAMP 11 h after the bite, and showed
progressive paralysis, despite having received five ampoules of
antivenom upon admission to the first hospital (in the city of origin).
At UNICAMP, the patient received a further five ampoules, with a
marked improvement in muscular activity (recovery from palpebral
ptosis and an ability to sit without help) after two i.v. doses (1 mg
each) of neostigmine. However, there was a marked worsening of
muscular force 10 min after the second injection of neostigmine, with
the need for a continuous infusion of this drug (12 µg/kg/h) that was
suspended after six h. There was no relapse to paralysis, and the patient
was discharged three days after admission (VITAL BRAZIL & VIEIRA,
1996). The third severe case involved a 10-year-old girl who had already
received three ampoules of antivenom in her home town where she
had developed palpebral ptosis, muscular weakness and superficial
respiration. The patient was admitted to UNICAMP six h after the
accident, with a worsening of myasthenia to the point that she was
unable to remain in an upright position. A therapeutic test with
edrophonium (0.25 mg/kg) produced no favorable response. A further
10 ampoules of antivenom were given and this was followed by the
progressive and total remission of paralysis. The patient was discharged
after three days.
Table 1
Sex, age, interval between bite and admission to the university hospital at
UNICAMP, and bite site in 11 patients bitten by coral snakes
Parameter Findings
Sex
     Male 6
     Female 5
Age in years: median, (range), and 27, (7- 48),
mean age ± 1 S.D. 27 + 13
Interval between bite and admission to 150 min,
hospital: median, (range) (45 min - 15 h)
     < 3 h 7
     3 - 6 h 2
     > 6 h 2
Bite site
     Fingers 3
     Hand 1
     Toes 1
     Foot 2
     Other 4
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Of the ten patients who received antivenom at UNICAMP (Table
2), mild early reactions occurred in three, with the patients showing
urticaria (3/10), itching (2/10) and abdominal pain (1/10).
DISCUSSION
Bites by Micrurus spp. in Brazil are rare, with very few deaths6,11,
and the cases described here confirm this situation. In the last 20 years,
only 11 cases with a confirmed diagnosis or strong suspicion of having
been caused by Micrurus spp. have been admitted to the university
hospital at UNICAMP, and accounted for 2% of the venomous
snakebites attended by this hospital (the remaining bites involved
Bothrops spp., 69.8%, and Crotalus durissus ssp., 28.2%).
In the present series, the hands and fingers were the regions most
frequently bitten, a finding that probably reflects the inappropriate or
imprudent handling of these snakes, as well as their habit of holding
on and chewing after the initial bite, a behavior which might prolong
the time of venom inoculation18,19,22,27. As shown here, and
elsewhere18,19,22,27, bites by Micrurus spp. may result in no clinical
manifestations of envenoming, i.e. dry-bites, despite the high toxicity
of Micrurus venoms. Occurrence of dry-bites can probably be explained
by the small to medium size of these snakes, their semifossorial habits,
low aggressivity, short fangs (generally < 3 mm), and the limited angle
of opening of the mouth (< 30º) making it difficult to inject venom
into humans and large animals20. The true incidence of dry-bites is
probably higher than that observed here since bites without
envenomation may be confused with those by non-venomous false coral
snakes (genera Erythrolampus, Liophis, Oxyrhopus, Pliocercus,
Simophis, and others) when there is no confirmed identification of the
offending species.
Pain and paresthesia were the most frequent local symptoms,
occasionally accompanied by myalgia and discrete edema, as also
reported elsewhere8,18-19,22,27,28,30. Although fang marks were detected in
only three cases, the absence of such marks does not exclude the
possibility that venom was inoculated and that there may be systemic
manifestations18,19,22,24,27.
The use of a tourniquet was reported in only one moderate case.
Table 2
Principal findings according to the severity of the bite in the 11 patients bitten by coral snakes
Findings Dry-bite Mild Moderate Severe Total
(n = 1) (n = 2) (n = 5) (n = 3) (n = 11)
Snake identified 1 2 0 1 4
Local
Paresthesia 1 1 5 2 9
Pain 0 1 4 3 8
Fang marks 0 0 2 1 3
Slight edema 0 1 1 0 2
Irradiating pain 0 0 1 1 2
Erythema 0 1 0 0 1
Myalgia 0 0 0 1 1
Systemic
Palpebral ptosis 0 0 5 3 8
Weakness 0 0 1 3 4
Inability to stand up 0 0 0 3 3
Muscle fasciculation 0 0 0 2 2
Diplopia 0 0 1 1 2
Superficial respiration 0 0 0 2 2
Headache 0 0 1 1 2
Blurred vision 0 0 1 1 2
Generalized paresthesia 0 0 1 1 2
Dysphagia 0 0 2 0 2
Vomiting 0 0 1 0 1
Salivation 0 0 1 0 1
Generalized myalgia 0 0 1 0 1
Muscle tremors 0 0 0 1 1
Anticholinesterases 0 0 0 3 3
Antivenom
Before arriving at UNICAMP 0 0 0 2 2
At UNICAMP 0 2 5 3 10
Number of ampoules per patient (median) 0 5-7(6) 6-12(10) 10-13(10) 5-13(10)
Early reactions 0 2 1 0 3
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There is some discussion regarding the efficacy of this procedure in
elapid bites. The quick release of a tourniquet after hospital admission
can result in fast deterioration of the patient´s clinical condition as a
result of a rapid, massive release of venom into the general circulation33.
A recent experimental study demonstrated that pressure-immobilization
bandages delayed the onset of the symptoms of envenomation and
increased the survival time in pigs injected with M. f. fulvius venom13.
However, no clinical trials have been performed to test this first aid
measure after Micrurus spp. snakebites. In addition, physicians and
lay people may have some difficulties in applying pressure-
immobilization bandages properly in a snakebite scenario25.
In four patients classified as moderate and in the three severe cases,
the onset of paralysis was rapid (1-3 h after the bite). A similar time
scale (2-4 h) has been reported for the appearance of neurological
manifestations after envenoming by M. f. fulvius27, although these
phenomena may also occur 7-18 h after the bite8,18-19. Regardless of the
time of onset, this paralysis worsens rapidly if adequate treatment is
not initiated and may result in the need for prolonged artificial
ventilation. Complete recovery from severe paralysis may require up
to two months18.
Part of the problem in deciding when to give antivenom in coral
snake bites is the difficulty in determining whether venom was in fact
injected18,27. The immunodiagnosis of coral snake bites is not a routine
procedure in Brazil, although ELISAs test for Micrurus venoms have
already been described3. Another consideration is whether the mild
cases (with confirmed identification of the snake) would have
progressed to paralysis if the patients had not received antivenom. Based
on the analysis of the moderate and severe cases reported here, and on
observations made ealsewhere18,27, we think that antivenom is
recommended in all cases with local manifestations (principally pain
and paresthesia) concomitant with systemic signs and symptoms of
acute myasthenia, regardless of the intensity, even without identification
of the snake. Although no controlled clinical trials have assessed the
efficacy of the elapidic antivenom used here, and there is no generally
accepted clinical classification of the severity of bites, the Brazilian
Ministry of Health nevertheless recommends an empirical dose of 10
ampoules of antivenom for elapid bites, regardless of the severity6.
Micrurus venoms are considered good immunogens, with good
cross-reactivity that neutralizes the lethal activity of venoms from
various species found in Brazil16,29. However, questions still remain
about the efficacy of antivenoms for treating bites by offending species
from different geographic origins10,21. Indeed, recent work has shown
that the antivenom produced by the Instituto Butantan is unable to
neutralize the lethality in mice of venom from M. altirostris (previously
classified as M. frontalis altirostris), an important species in the
southern Brazilian state of Rio Grande do Sul21. The use of a polyvalent
antivenom against the main Micrurus species of North, Central and
South America10 could perhaps overcome problems related to regional
and intergeneric venom variations.
A clinical trial involving Naja naja philippinensis bites34 has shown
the effectiveness of anticholinesterase drugs in treating elapid
envenoming with severe paralysis caused by a predominantly or
exclusively postsynaptic action at the neuromuscular junction. A
favorable response to neostigmine in three cases has also been observed
in Brazil, two of which were attended a considerable time after being
bitten8,32. In one of our cases, which did not respond to anticholinesterase
drugs, the offending species may have been M. corallinus, which venom
acts presynaptically blocking the release of acetylcholine from nerve
endings at the neuromuscular junction17,31. However, the effect of
neostigmine is always temporary8,32,34, and complete reversal of post-
synaptic neurotoxicity can be achieved only with antivenom.
In conclusion, the results described here indicate that bites by
Brazilian Micrurus spp. should always be considered as potentially
serious, although the prognosis for those bitten who developed
envenoming is quite good, as long as adequate therapeutic measures
are adopted. Such measures include the administration of antivenom
and the provision of respiratory support, if necessary. In serious bites
by M. frontalis or M. lemniscatus, whose venoms act postsynaptically,
anticholinesterases may be useful as an ancillary measure if antivenom
is unavailable, if there is a delay in obtaining a sufficient amount, or in
those patients given the highest recommended doses of antivenom
without improvement of the paralysis or with delayed recovery.
RESUMO
Acidentes por serpentes corais (Micrurus spp.) em Campinas,
Estado de São Paulo, sudeste do Brasil
As serpentes corais (Micrurus spp.) são as principais representantes
dos elapídeos na América do Sul. Todavia, acidentes com essas
serpentes são raros. Foram revisados retrospectivamente os prontuários
de 11 pacientes mordidos por corais num período de 20 anos. Destes
11 casos, quatro foram casos confirmados por identificação da serpente
e sete como casos altamente suspeitos de envenenamento elapídico
por apresentarem manifestações neuromusculares indicativas de
miastenia aguda. Os casos foram classificados como não envenenados
[n = 1, causado por M. lemniscatus, não recebeu antiveneno (AV)],
leves (manifestações locais sem miastenia, n = 2, causados por M.
frontalis e M. spp.), moderados (miastenia leve, n = 5) e graves
(miastenia intensa, n = 3, um causado por M. frontalis). Os principais
achados clínicos à admissão foram: parestesia (local, n = 9;
generalizada, n = 2), dor local (n = 8), ptose palpebral (n = 8), fraqueza
(n = 4), incapacidade de se manter na posição ereta (n = 3). Nenhum
paciente desenvolveu insuficiência respiratória. O AV elapídico foi
empregado em 10 casos, ocorrendo reações precoces leves em três.
Em três pacientes foram administrados anticolinesterásicos, com
resposta favorável em dois. Não ocorreram óbitos. A despeito da alta
toxicidade dos venenos de Micrurus spp., o prognóstico do
envenenamento é bom. Nos casos graves determinados por M. frontalis
e M. lemniscatus, cujos venenos atuam pós-sinapticamente, o uso de
anticolinesterásicos pode ser considerado caso o AV não seja disponível;
caso ocorra um atraso para a sua obtenção; ou nos pacientes que
receberam as mais altas doses de AV recomendadas sem melhora da
paralisia ou demora na reversão desses sintomas.
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